The intrinsic gene expression signatures in breast cancer were discovered by DNA microarray technology that classifies breast cancer into the molecular subtypes predominantly as luminal A, luminal B, HER2-enriched and basal-like [12]. This evidence concerns the gene ERBB2 and breast carcinoma.